PA-300

N/A

Report date: 2023/05/22 10:16:45
NME

Base Information

Drug NamePA-300
Drug Alias NameN/A
ClassificationSmall molecules
Mechanisms of ActionAdenosylmethionine decarboxylase inhibitors
TargetsAdenosylmethionine decarboxylase
Therapy Area/IndicationsMultiple SclerosisMusculoskeletal Pain
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesPathologica
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesPathologica
Active IndicationsN/A
Inactive IndicationsMultiple SclerosisMusculoskeletal Pain

Other Information

ATC CodeN/A
Related LinksN/A